SCHEMBL18831968

SCHEMBL18831968

CCCCCCCC/C=C\CCCCCCCCNC(=O)c1cc(C(=O)NCCCCCC)c(C(=O)NCCCCCC)cc1C(=O)NCCCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.56
EPHX2 P34913 8/20 0.55
CNR1 P21554 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14812246 0.90 NAAA (0.66) NAAA
SCHEMBL14812810 0.90 NAAA (0.66) NAAA
SCHEMBL14816297 0.90 NAAA (0.66) NAAA
Dectaflur SCHEMBL18831969 0.88 SLC6A5 (0.59) NAAAEPHX2
SCHEMBL18124409 0.86 TSHR (0.46) NAAAEPHX2
SCHEMBL18124417 0.86 TSHR (0.46) NAAAEPHX2
SCHEMBL18831972 0.86 TSHR (0.46) NAAAEPHX2
SCHEMBL2638660 0.83 NAAA (0.59) NAAA
SCHEMBL15820610 0.83 NAAA (0.84) NAAAEPHX2
SCHEMBL15820606 0.83 NAAA (0.84) NAAAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10011561-B2 Thickening/stabilizing agent and thickened/stabilized composition using the same DAICEL CORPORATION (JP) 2018-07-03 US disclosed
US-20170137373-A1 THICKENING/STABILIZING AGENT AND THICKENED/STABILIZED COMPOSITION USING THE SAME DAICEL CORPORATION (JP) 2017-05-18 US disclosed
EP-3168209-A1 THICKENING AGENT AND COMPOSITION THICKENED USING SAME Daicel Corporation (JP) 2017-05-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170137373-A1 THICKENING/STABILIZING AGENT AND THICKENED/STABILIZED COMPOSITION USING THE SAME GRN, CNOT1, HRH1 NAAA 3062/4885EPHX2 3027/4885CNR1 42/4885
US-10011561-B2 Thickening/stabilizing agent and thickened/stabilized composition using the same HRH1, HRH3, GRN NAAA 2821/4885EPHX2 3307/4885CNR1 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.